Canlyniadau Chwilio - Schmitt, Andreas Michael

Characteristics and survival of patients with cancer with intended off-label use—a cohort study gan Schmitt, Andreas Michael, Walter, Martin, Herbrand, Amanda Katherina, Jörger, Markus, Moffa, Giusi, Novak, Urban, Hemkens, Lars, Kasenda, Benjamin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project gan Herbrand, Amanda Katherina, Schmitt, Andreas Michael, Briel, Matthias, Diem, Stefan, Ewald, Hannah, Hoogkamer, Anouk, Joerger, Markus, Mc Cord, Kimberly Alba, Novak, Urban, Sricharoenchai, Sirintip, Hemkens, Lars G, Kasenda, Benjamin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study gan Kasenda, Benjamin, Liu, Junhao, Jiang, Yu, Gajewski, Byron, Wu, Cen, von Elm, Erik, Schandelmaier, Stefan, Moffa, Giusi, Trelle, Sven, Schmitt, Andreas Michael, Herbrand, Amanda K., Gloy, Viktoria, Speich, Benjamin, Hopewell, Sally, Hemkens, Lars G., Sluka, Constantin, McGill, Kris, Meade, Maureen, Cook, Deborah, Lamontagne, Francois, Tréluyer, Jean-Marc, Haidich, Anna-Bettina, Ioannidis, John P. A., Treweek, Shaun, Briel, Matthias

Cael y testun llawn Cael y testun llawn Cael y testun llawn